FDA Approved: CYTARABINE — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approves Meitheal Pharmaceuticals' original application for CYTARABINE (cytarabine) as a generic injectable product, enabling its marketing in the Unite…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Meningeal Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• CYTARABINE (CYTARABINE)

Snippet

ORIG AP for CYTARABINE (CYTARABINE)